Argenx Se (ARGX) Operating Margin Growth (3y) (2019 - 2026)
Argenx Se (ARGX) Operating Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 7,794.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 6,993.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,794.00 |
| Dec 31, 2025 | 9,459.00 |
| Sep 30, 2025 | 18,959.00 |
| Jun 30, 2025 | 25,444.00 |
| Mar 31, 2025 | 107,003.00 |
| Dec 31, 2024 | 90,135.00 |
| Sep 30, 2024 | 248.00 |
| Jun 30, 2024 | 2,062.44 Bn |
| Mar 31, 2024 | 821.98 Bn |
| Dec 31, 2023 | 176,663.00 |
| Sep 30, 2023 | -8,379.00 |
| Jun 30, 2023 | 12,559.00 |
| Mar 31, 2023 | 45,603.00 |
| Dec 31, 2022 | 154,317.00 |
| Sep 30, 2022 | -196,628.00 |
| Jun 30, 2022 | 45,083.00 |
| Mar 31, 2022 | -103,586.00 |
| Dec 31, 2021 | -51,592.00 |
| Sep 30, 2021 | -40,071.00 |
| Jun 30, 2021 | -2,062.44 Bn |